Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey

Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terv...

Descrición completa

Detalles Bibliográficos

Principais autores:	Katarzyna Bobeff, Agata Pastorczak, Zuzanna Urbanska, Walentyna Balwierz, Edyta Juraszewska, Jacek Wachowiak, Katarzyna Derwich, Magdalena Samborska, Krzysztof Kalwak, Iwona Dachowska-Kalwak, Paweł Laguna, Iwona Malinowska, Katarzyna Smalisz, Jolanta Gozdzik, Aleksandra Oszer, Bartosz Urbanski, Maciej Zdunek, Tomasz Szczepanski, Wojciech Mlynarski, Szymon Janczar
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2023-04-01
Series:	Children
Assuntos:	venetoclax ABT-199 BH3 mimetics acute lymphoblastic leukaemia acute myeloid leukaemia juvenile myelomonocytic leukaemia
Acceso en liña:	https://www.mdpi.com/2227-9067/10/4/745
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!